Publications by authors named "Gregory Behbehani"

Claim this Profile
S
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AML.
Jayanshu Jain, Kelly Pugh, Shivani Handa, Kaitlyn M Dvorak-Kornaus, Qiuhong Zhao, Gregory K Behbehani

Blood Neoplasia· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL10-induced chemotaxis of -expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcoma.
Shiori Eguchi, Wen Luo, Hongwen Zhu, Hai M Hoang, Changxin Xu, Gregory K Behbehani

Mol Ther Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Juvenile myelomonocytic leukemia stem cells are sensitive to NK cell-mediated lysis and express targetable antigens.
Shannalee Martinez, Vladimir V Senyukov, Suheyla Hasgur, Arianexys Aquino-López, Peter D Emanuel, Gregory Behbehani

Blood Neoplasia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer.
Emily Schwarz, Himanshu Savardekar, Sara Zelinskas, Abigail Mouse, Gabriella Lapurga, Gregory K Behbehani

Cancer Immunol Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies.
Ella Troy, Joseph Caporale, Yasemin Sezgin, Marcelo S F Pereira, Gregory Behbehani

Blood Neoplasia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors.
Emily Schwarz, Brooke Benner, Robert Wesolowski, Dionisia Quiroga, Logan Good, Gregory Behbehani

JCI Insight· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
: A protein-coding circular RNA that regulates DNA damage response in -positive leukemias.
Dimitrios Papaioannou, Amog P Urs, Rémi Buisson, Andreas Petri, Rohan Kulkarni, Gregory K Behbehani

bioRxiv· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E in a preclinical model of pleomorphic Xanthoastrocytoma: Analysis of the tumor microenvironment and immune cell infiltration dynamics .
Alessandro Canella, Matthew Nazzaro, Mykyta Artomov, Lakshmi Prakruthi Rao Venkata, Diana Thomas, Gregory Behbehani

Mol Ther Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 and in NB xenografts.
Yaya Chu, Gaurav Nayyar, Meijuan Tian, Dean A Lee, Mehmet F Ozkaynak, Gregory K Behbehani

Mol Ther Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a phase I trial with Haploidentical mbIL-21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML.
Stefan O Ciurea, Piyanuch Kongtim, Samer Srour, Julianne Chen, Doris Soebbing, Gregory Behbehani

Am J Hematol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia.
Bhavana Bhatnagar, Qiuhong Zhao, Alice S Mims, Sumithira Vasu, Gregory K Behbehani

Leuk Lymphoma· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetically modified IL2 bone-marrow-derived myeloid cells reprogram the glioma immunosuppressive tumor microenvironment.
Alessandro Canella, Matthew Nazzaro, Sakthi Rajendran, Claire Schmitt, Abigail Haffey, Gregory K Behbehani

Cell Rep· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass Cytometry as a Tool for Investigating Senescence in Multiple Model Systems.
Amina Abdul-Aziz, Raymond D Devine, Justin M Lyberger, Hsiaochi Chang, Amy Kovacs, Gregory K Behbehani

Cells· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative Disorder.
Elshafa Hassan Ahmed, Mark Lustberg, Claire Hale, Shelby Sloan, Charlene Mao, Gregory K Behbehani

Cancers (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacture and Characterization of Good Manufacturing Practice-Compliant SARS-COV-2 Cytotoxic T Lymphocytes.
Yaya Chu, Jordan Milner, Margaret Lamb, Elena Maryamchik, Olivia Rigot, Gregory K Behbehani

J Infect Dis· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Gregory K Behbehani

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV.
Meisam Naeimi Kararoudi, Shibi Likhite, Ezgi Elmas, Kenta Yamamoto, Maura Schwartz, Gregory K Behbehani

Cell Rep Methods· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer.
Justin Thomas, Molly A Torok, Kriti Agrawal, Timothy Pfau, Trang T Vu, Gregory K Behbehani

Int J Mol Sci· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.
Swagata Goswami, Rajeswaran Mani, Jessica Nunes, Chi-Ling Chiang, Kevan Zapolnik, Gregory Behbehani

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patients.
Kristin L Koenig, Thomas P Curley, Shylaja Mani, Ashleigh Keiter, Qiuhong Zhao, Gregory K Behbehani

Hematol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decrease post-transplant relapse using donor-derived expanded NK-cells.
Stefan O Ciurea, Piyanuch Kongtim, Doris Soebbing, Prashant Trikha, Gregory Behbehani

Leukemia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Genomic analysis of cellular hierarchy in acute myeloid leukemia using ultrasensitive LC-FACSeq.
Caner Saygin, Eileen Hu, Pu Zhang, Steven Sher, Arletta Lozanski, Gregory Behbehani

Leukemia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the Pyrimidine Analog, 5-Iodo-2'-Deoxyuridine (IdU) with Cell Cycle Markers to establish Cell Cycle Phases in a Mass Cytometry Platform.
Raymond D Devine, Gregory K Behbehani

J Vis Exp· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.
Victoria E Wang, Bradley W Blaser, Ravi K Patel, Gregory K Behbehani, Arjun A Rao

Blood Cancer Discov· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through metabolic reprogramming.
Hongji Zhang, Tianmeng Chen, Jinghua Ren, Yujia Xia, Amblessed Onuma, Gregory K Behbehani

Nat Metab· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis